Viridian Therapeutics, Inc.\DE

By person

23 insiders · 71 transactions

1.1×

Stephen Mahoney holds only 1.1 times base salary in stock. $811.69K of shares against $700.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Stephen Mahoney last reported holding, valued at $24.50, the price Common Stock was last bought or sold at on the open market here, on 19 Aug 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Fairmount Funds Management LLC entity

Director

$90.00M (6)

—

+$90.00M

5,617,321

4.96%

$137.62M

+15,907%

Violin Jonathan

Chief Executive Officer

—

$4.27M (10)

−$4.27M

430,905

0.3803%

$10.56M

—

Katz Barrett

Chief Medical Officer

—

$3.17M (4) scheduled

−$3.17M

0.0000%

$0.00

—

Booth Bruce

Director

$3.00M (1)

—

+$3.00M

3,142,580

2.77%

$76.99M

+21.0%

Meisner Lara

Chief Legal Officer

—

$2.54M (14) scheduled

−$2.54M

29,971

0.0265%

$734.29K

−50.0%

Logos Global Master Fund LP entity

10% owner

$2.27M (3)

—

+$2.27M

550,000

0.4855%

$13.48M

+650.0%

Frazier Life Sciences Public Fund, L.P. entity

10% owner

$2.20M (1)

—

+$2.20M

1,505,200

1.33%

$36.88M

+15.3%

LEFKOFF KYLE

Director

—

$540.14K (10)

−$540.14K

463,473

0.4091%

$11.36M

−7.4%

Mahoney Stephen F.

President and CEO

$499.26K (1)

—

+$499.26K

33,130

0.0292%

$811.69K

+3,213%

Tousignant Jennifer

Chief Legal Officer

—

$418.99K (3) scheduled

−$418.99K

0.0000%

$0.00

−100.0%

Myers Scott Dunseth

Chief Executive Officer

$261.80K (2)

—

+$261.80K

259,500

0.2291%

$6.36M

—

Beetham Thomas W.

Chief Operating Officer

$117.05K (1)

—

+$117.05K

13,271

0.0117%

$325.14K

+563.6%

Levy Adam Scott

Chief Business Officer

$51.51K (2)

—

+$51.51K

13,040

0.0115%

$319.48K

+247.7%

Hughes Thomas E.

Director

$47.70K (1)

$96.00K (1)

−$48.30K

12,827

0.0113%

$314.26K

−8.7%

Riccitelli Samuel D

President & CEO

—

571,370

0.5043%

$14.00M

+20.4%

LEBOW BENNETT S

Director

—

429,441

0.3791%

$10.52M

+187.9%

Marshall William Stuart

See Remarks

—

273,146

0.2411%

$6.69M

+73.6%

FAVORITO TAMARA A

CFO, Secretary, Treasurer

—

106,447

0.0940%

$2.61M

+294.3%

Leverone Jason A.

Chief Financial Officer

—

48,829

0.0431%

$1.20M

+885.1%

Tripuraneni Radhika

Chief Medical Officer

—

40,000

0.0353%

$980.00K

—

Harmon Seth

Chief Financial Officer

—

7,790

0.0069%

$190.86K

+115.6%

Smith Robin L

Director

—

1,900

0.0017%

$46.55K

+171.4%

Gonyer David A

Director

—

1,899

0.0017%

$46.53K

+171.7%

Individual transactions

Insider

Date

Role

Action

Price

Amount

Tousignant Jennifer

19 Aug 2026

Chief Legal Officer

Sold after exercise

10,000

$24.50

$245.00K

Tousignant Jennifer

19 Aug 2026

Chief Legal Officer

Sold after exercise

4,212

$24.50

$103.19K

Meisner Lara

16 Jun 2023

Chief Legal Officer

Sold after exercise

$28.35

$765.45

Meisner Lara

15 Jun 2023

Chief Legal Officer

Sold after exercise

2,269

$28.02

$63.58K

Meisner Lara

6 Jun 2023

Chief Legal Officer

Sold after exercise

5,126

$25.02

$128.25K

Meisner Lara

5 Jun 2023

Chief Legal Officer

Sold after exercise

499

$25.03

$12.49K

Meisner Lara

2 Jun 2023

Chief Legal Officer

Sold after exercise

1,875

$24.21

$45.39K

Meisner Lara

23 Jan 2023

General Counsel and Secretary

Sold after exercise

6,843

$35.66

$244.02K

Katz Barrett

17 Jan 2023

Chief Medical Officer

Sold after exercise

24,853

$37.21

$924.78K

Katz Barrett

13 Jan 2023

Chief Medical Officer

Sold after exercise

4,147

$37.01

$153.48K

Katz Barrett

10 Jan 2023

Chief Medical Officer

Sold after exercise

47,377

$35.30

$1.67M

Katz Barrett

9 Jan 2023

Chief Medical Officer

Sold after exercise

12,623

$33.04

$417.06K

Meisner Lara

21 Dec 2022

General Counsel and Secretary

Sold after exercise

16,326

$29.19

$476.56K

Meisner Lara

20 Dec 2022

General Counsel and Secretary

Sold after exercise

600

$28.07

$16.84K

Meisner Lara

16 Dec 2022

General Counsel and Secretary

Sold after exercise

1,297

$28.44

$36.89K

Meisner Lara

15 Dec 2022

General Counsel and Secretary

Sold after exercise

300

$28.08

$8.42K

Meisner Lara

14 Dec 2022

General Counsel and Secretary

Sold after exercise

15,656

$28.12

$440.25K

Meisner Lara

12 Dec 2022

General Counsel and Secretary

Sold after exercise

600

$28.05

$16.83K

Meisner Lara

15 Nov 2022

General Counsel and Secretary

Sold after exercise

8,125

$22.05

$179.16K

Show all 71 transactions →

Viridian Therapeutics, Inc.\DE

By person

Individual transactions

What was left out